A regional venture bringing QES to Saudi Arabia and the GCC

Saudi Arabia is investing at scale in biotechnology, genomics, local pharmaceutical manufacturing and precision health. What the ecosystem lacks is not ambition or capital but measurement throughput: analytical capacity that is fast, affordable and available inside the region rather than shipped abroad.

Quantabia licenses Probius technology and commercializes it as a regional platform — instruments placed in Saudi and GCC laboratories, cloud analysis with regional data residency options, and scientists on the ground who speak the language of both the clinic and the production floor.

Our aim is straightforward: make high-fidelity, AI-ready biological data an everyday resource for researchers, hospitals and manufacturers across the Gulf.